Drug Use Practices and Self-Treatment for Suspected Malaria in Ibadan, Nigeria

Am J Trop Med Hyg. 2023 Apr 17;108(6):1122-1126. doi: 10.4269/ajtmh.22-0489. Print 2023 Jun 7.

Abstract

Antimalarial drug failures have been reported anecdotally in Nigeria, and malarial self-treatment practices could be a contributing factor. This study was designed to assess the pattern of drug use practices and self-treatment options among caregivers in Ibadan, Nigeria. We carried out a descriptive cross-sectional study among 283 study participant pairs (children under 5 years of age with suspected malaria and their caregivers). Structured questionnaires were used as research instruments. The results indicated that most caregivers were mothers (88.8%), 69% of caregivers self-prescribed and self-managed malaria for children under 5 years old without immediate hospital visits, and 76.4% of the caregivers believed most recommended and available antimalarial drugs were ineffective. Generally, 44.2% of respondents preferred and used antibiotics as a treatment strategy for malaria, 13.2% used agbo (a locally made liquid extract of plants and roots), 12.5% used prayers, and 19.6% used antimalarial drugs. Overall, only 57.1% of respondents stated that they always complete the standard antimalarial dosage regimen. The choice of malaria self-treatment options was significantly linked to the level of education. The findings identified antibiotics, agbo, and prayers as the immediate choices for self-treating malaria disease in Ibadan. Furthermore, incomplete adherence to antimalarial drugs is a general practice in Ibadan. Malaria self-treatment policy and continuous education on antimalarial drug use tailored to the different literacy and education levels of the general public is hereby recommended to reduce the risk of development of parasite resistance to effective anti-malarial drugs.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimalarials* / therapeutic use
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Folic Acid Antagonists* / therapeutic use
  • Humans
  • Malaria* / drug therapy
  • Nigeria / epidemiology

Substances

  • Antimalarials
  • Folic Acid Antagonists
  • Anti-Bacterial Agents